Upcoming Phase 3 Clinical Program Will Examine Efficacy of Oral ...

Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE ...

The Company expects topline results early in the fourth quarter of 2024 and anticipates filing a supplemental New Drug Application to the U.S. ...

10 clinical trials to watch in the first half of 2023 | BioPharma Dive

Answers could be coming shortly. A Phase 3 study of Moderna's shot, mRNA-1010, is fully enrolled, with results expected in the first quarter.

Shionogi Provides Updates on Zatolmilast, an Investigational Drug ...

No participants discontinued the study due to adverse events.2. Zatolmilast is being evaluated in a pivotal Phase 2b/3 program in the U.S. ...

Pfizer Announces Additional Phase 2/3 Study Results Confirming ...

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing ...

Vertex Announces Positive Results From the VX-548 Phase 3 ...

The Phase 3 program included two randomized, double-blind, placebo-controlled, pivotal trials, one following abdominoplasty surgery and one ...

News Release - Eli Lilly Investors

... diabetes in the ACHIEVE phase 3 clinical program. INDIANAPOLIS , June 23, 2023 ... Lilly has initiated phase 3 development programs to further study the ...

Clinical trials of new drugs for Alzheimer disease: a 2020–2023 ...

The phase 3 trial APOLLOE4 (NCT04770220) is evaluating the safety and efficacy of ALZ-801 for patients with early AD and carrying the ...

Understanding the Phases and Types of Clinical Trials

* Approximately 25-30% of drugs in Phase 3 studies will move to the next phase or approval per the FDA. Phase 4: Phase 4 trials are observational or registry ...

Gliofocus - Phase 3 Study of Niraparib for Glioblastoma

The Gliofocus Study is a global, open-label, randomized Phase 3 clinical trial sponsored by the Ivy Brain Tumor Center that will compare the efficacy of ...

Clinical Trial Opportunities | Myasthenia Gravis Foundation of America

The study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in ...

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in ...

BG-12 (dimethyl fumarate) is in development as an oral treatment for relapsing–remitting multiple sclerosis, which is commonly treated with ...

Treatment Clinical Trials for Small Cell Lung Cancer - NCI

The estimated duration of the study is up to 3 years. There may be higher treatment burden for participants in this trial compared to their standard of care.

Shionogi Clinical Trials in the U.S.

is a Phase 1, randomized, double-blind, controlled, drug-drug interaction and multiple-dose pharmacokinetics and safety study of xeruborbactam oral prodrug ( ...

Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment ...

Participants enrolled in Cohort 2 will receive PAXLOVID (nirmatrelvir/ritonavir 150 mg/100 mg) orally twice daily for five days (10 doses total) ...

22 Case Studies Where Phase 2 and Phase 3 Trials Had Divergent ...

placebo, and another phase 3 trial compared its efficacy with oral olanzapine. Both studies confirmed that the new long-acting formulation was effective in ...

Phases of Clinical Trials - MD Anderson Cancer Center

Phase III trials test if a new treatment is better than a standard treatment. Phase IV trials find more information about long-term benefits and side effects.

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized ...

The primary efficacy end point was the incidence hospitalization or death at day 29; the incidence of adverse events was the primary safety end ...

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of ...

... (3, 7, and 14 mg) were selected for the phase 3 program. Here, we present the results of the first completed phase 3 trial with oral ...

Phases of clinical research - Wikipedia

The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a ...

Current Research Studies & Pipeline - Dravet Syndrome Foundation

*More than one Phase III study may be required before a New Drug Application (NDA) may be submitted to the FDA. Clinical Trials Glossary.